These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 18645252

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Ovarian histopathology in breast cancer patients receiving tamoxifen.
    McGonigle KF, Vasilev SA, Odom-Maryon T, Simpson JF.
    Gynecol Oncol; 1999 Jun; 73(3):402-6. PubMed ID: 10366467
    [Abstract] [Full Text] [Related]

  • 23. Prognosis of uterine corpus cancer after tamoxifen treatment for breast cancer.
    Hoogendoorn WE, Hollema H, van Boven HH, Bergman E, de Leeuw-Mantel G, Platteel I, Fles R, Nederlof PM, Mourits MJ, van Leeuwen FE, Comprehensive Cancer Centers TAMARISK-group.
    Breast Cancer Res Treat; 2008 Nov; 112(1):99-108. PubMed ID: 18064567
    [Abstract] [Full Text] [Related]

  • 24. Pleomorphic liposarcoma of the uterus: case report and literature review.
    Levine PH, Wei XJ, Gagner JP, Flax H, Mittal K, Blank SV.
    Int J Gynecol Pathol; 2003 Oct; 22(4):407-11. PubMed ID: 14501826
    [Abstract] [Full Text] [Related]

  • 25. Long-term effects of the levonorgestrel-releasing intrauterine system on serum lipids and the endometrium in breast cancer patients taking tamoxifen.
    Kesim MD, Aydin Y, Atis A, Mandiraci G.
    Climacteric; 2008 Jun; 11(3):252-7. PubMed ID: 18568790
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer.
    Hubalek M, Ramoni A, Mueller-Holzner E, Marth C.
    Gynecol Oncol; 2004 Oct; 95(1):264-6. PubMed ID: 15385144
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Papillary serous carcinoma arising from adenomyosis presenting as intramural leiomyoma.
    Izadi-Mood N, Samadi N, Sarmadi S, Eftekhar Z.
    Arch Iran Med; 2007 Apr; 10(2):258-60. PubMed ID: 17367236
    [Abstract] [Full Text] [Related]

  • 33. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G, Cellani F, Centinaio G, Sita G, Nalli G, Luerti M.
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Uterine malignant mixed müllerian tumor in a patient on long-term tamoxifen therapy for breast cancer.
    Clarke MR.
    Gynecol Oncol; 1993 Dec; 51(3):411-5. PubMed ID: 8112655
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.